Candel Therapeutics Inc (CADL) — Financial Flexibility Index
Candel Therapeutics Inc (CADL) has a Financial Flexibility Index of -0.14x as of December 2025. Free cash flow of $-10.16 Million (operating CF $-10.57 Million minus capex $409.00K) represents 0% of total liabilities ($73.27 Million). Also explore how fast is Candel Therapeutics Inc growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Candel Therapeutics Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Candel Therapeutics Inc across 7 annual periods. Check Candel Therapeutics Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Candel Therapeutics Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Candel Therapeutics Inc. For the full company profile including market capitalisation, see market value of Candel Therapeutics Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.51x | $-37.72 Million | $-38.31 Million | $73.27 Million | ▲ +22.7% |
| 2024 | -0.67x | $-27.01 Million | $-27.02 Million | $40.54 Million | ▲ +43.9% |
| 2023 | -1.19x | $-33.79 Million | $-34.24 Million | $28.46 Million | ▼ -21.4% |
| 2022 | -0.98x | $-30.12 Million | $-31.42 Million | $30.80 Million | ▼ -20.3% |
| 2021 | -0.81x | $-20.38 Million | $-22.22 Million | $25.07 Million | ▼ -562.1% |
| 2020 | -0.12x | $-7.59 Million | $-9.07 Million | $61.84 Million | ▼ -32.0% |
| 2019 | -0.09x | $-5.02 Million | $-5.18 Million | $53.94 Million | — |